A Study of JNJ 73763989+JNJ 56136379+Nucleos(t)Ide Analog (NA) Regimen Compared to NA Alone in e Antigen Negative Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection
Condition: Hepatitis B, Chronic Interventions: Drug: JNJ-73763989; Drug: JNJ-56136379; Drug: Placebo for JNJ-73763989; Drug: Placebo for JNJ-56136379; Drug: Entecavir (ETV) monohydrate; Drug: Tenofovir disoproxil fumarate (TDF); Drug: Tenofovir alafenamide (TAF) Sponsor: Janssen Research & Development, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials